REVISTA DE GINECOLOGÍA Y OBSTETRICIA 

Agradecimientos

Al Centro de Investigaciones Médicas de la Facultad de Medicina y al Comité para el Desarrollo de la Investigación de la Universidad de Antioquia por la financiación y apoyo ofrecidos para esta investigación.

 

Bibliografía

1. E.U. Population Reference Bureau (PRB). Resumen de las conclusiones del Consejo Nacional de Investigación de la Academia Nacional de Ciencias de los E.U. "Cómo mejorar la salud reproductiva de los países en desarrollo". Washington. Oct. 1997.

2. Presidencia de la República, Departamento Nacional de Planeación, Ministerio de Salud y otros. "Mortalidad Materna en Colombia". Santafé de Bogotá, agosto 1996.

3. Ness R., Roberts JM. Heterogeneous causes constituting the single syndrome of Preeclampsia: A hypothesis and its implications. Am J Obstet Gynecol 1996; 175: 1365-70.

4. Lockwood CJ., Rand J. The Inmunobiology and Obstetrical Consecuences of Antiphospholipid Antibodies. Obstet Gynecol Survey. 1994; 49: 432-40.

5. Dekker G., de Vries J., Doelitzsch P., et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995; 173: 1042-8.

6. Harris E., Spinnato J. Should anticardiolipin tests be performed in otherwise healthy pregnant women? Am J Obstet Gynecol 1991;165 part 1: 1272-77.

7. El-Roely A., Collicher N. Definition of Normal Autoantibody leves in apparently healthy population. Obstet Gynecol 1988; 72: 596-602.

8. Fields RA., Toubbeh H., Scarles RP. The Prevalence of the Anticardiolipin antibodies in healty elderly population and its association with antinuclear antibodies. J Rheumatol. 1989; 16: 623-25.

9. The Anticardiolipin Wet Workshop. Fifth International Symposium on Antiphospholipid Antibodies, San Antonio, sept 13, 1992.

10. Branch D., Andrés R., Digre K., et al. The association of Antiphospholipid Antibodies With Severe Preeclampsia. Obstet Gynecol 1989; 73: 541-45.

11. Yasuda M., Takakuwa K., Tokunaga A., Tanaka K. Prospective Studies of the Association Between Anticardiolipin Antibody and Outcome of Pregnancy. Obstet Gynecol 1995; 86: 555-9.

12. Petri M., Rheinschmidt M., Whitting-O'Keete Q., et al. The Frecuency of Lupus Anticoagulant in Systemic Lupus Erytemathousus. Ann Intern Med 1987; 106: 524-531.

13. Matsuura E., Igarashi Y., Fujimoto M., et al. Imoproved enzyme immunoassay for anticardiolipin antibody: A highly specific assay for antiphospholipid syndrome. Clin Exp Rheumatol 1990; 8: 204.

14. Galli M. Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. The Lancet 1990; 335: 1544-47.

15. Matsuura E., Igarashi Y., Fujimoto M., et al. Heterogeneity anticardiolipin antibodies defined by the anticardiolipin cofactor. J. Immunol 1992; 148: 3885-91.

16. Katano K., Aoki K., Sasa H et al. B2-Glycoprotein I dependent anticardiolipin antibodies as a predictor of adverse pregnancy outcomes in healthy pregnant women. Hum Reprod 1996; 11: 509-12.

17. Faden D. Anti-beta 2 glycoprotein I antibodies in a general obstetric population: preliminary results on the prevalence and correlation with pregnancy outcome. Anti-b2 glycoprotein I antibodies are associated with some obstetrical complications, mainly preeclampsia-eclampsia. Europ Jour Obstet Gynecol Reprod Biol 1997; 73: 37- 421.

18. Hadlock FP., Harrist RB., Martínez-Poyer J. In útero analysis of fetal growth: A sonographic weigths standar.Radiology 1991; 181: 129-33.

19. Kupferminc M., Eldor A., Steinman N., et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.

20. Pampus van MG., Wolf H., Buller HR., et al. Underlying disorders associated with severe preeclampsia and hellp syndrome.Am J Obstet Gynecol 1997; 175: s26 (Abstracts SPO 1997).

21. Rajah SB., Moodley J., Pudifin D., et al. Anticardiolipin antibodies in Hypertensive emergencies. Clin and exper hipertens pregnancy 1990; B9: 267-27.

22. Out HJ., Bruinse HW., Christiaens GCML., et al. A prospective, controlled multicenter study on the obstetric risks of pregnant women with antiphospholipid antibodies. Am J Obstet Gynecol 1992; 167: 26-32.